SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
ADPT

Adaptive Biotechnologies Corp (ADPT)

NASDAQ: ADPT · Real-Time Price · USD
Healthcare · Diagnostics & Research
26.21+0.70 (+2.76%)
 
Market cap
$4.18B
Analyst consensus
Insider Score
––Not scored
ADPT Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

ADPT analyst forecast

ADPT analyst consensus

No analyst ratings in the last 3 months.

ADPT 12-month price target

$35.00+33.5% upsideaverage of 1 firm
$35.00High
$35.00Low

Best analysts covering ADPT

No firm covering ADPT has enough calls with a finished 1Y holding period to rank yet.

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

ADPT analyst ratings

FirmPrice targetAction
Goldman Sachs—$35.00+22.8%—2026-09-29
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.